#United States #Salt Lake City #EVŌQ Nano #Tony Robbins #Antimicrobial Technology

A Strategic Partnership in Nanotechnology

SALT LAKE CITY, Jan. 30, 2025 - EVŌQ Nano, a leading company focusing on nanoscience, has received a significant investment from Tony Robbins, a global business visionary and philanthropist. This partnership aims to enhance the development of EVŌQ Nano’s innovative antimicrobial nanoparticle technology, which addresses one of the most pressing health threats today: antimicrobial resistance.

Mr. Robbins, well-known for his motivational speaking and success coaching, expressed his commitment to health technologies that can lead to meaningful global impact. He highlighted the urgent need for solutions in combating antibiotic-resistant bacteria, which is recognized as a top threat by the World Health Organization (WHO).

In the face of rising antimicrobial resistance, EVŌQ Nano's platform has shown remarkable efficacy against the six bacteria strains identified by WHO as critical threats. This unique technology not only combats these bacteria but also does so without facilitating resistance development, potentially transforming infection management and prevention strategies.

Expanding Technology for Better Health Outcomes

The strategic investment will help steer multiple initiatives within EVŌQ Nano, focusing on therapeutic solutions in healthcare, innovative medical devices, and antimicrobial applications in textiles. This three-pronged approach aims to tackle health-related issues from various angles:

1. Advancing Therapeutic Antimicrobial Solutions:
EVŌQ Bio, a subsidiary of EVŌQ Nano, is in the process of developing a groundbreaking inhaled therapeutic, EVQ-218. This targeted approach aims to treat pulmonary bacterial infections, particularly among cystic fibrosis patients, thus significantly enhancing their quality of life. A recent successful FDA pre-investigational new drug meeting has paved the way for upcoming clinical trials.

2. Integrating Antimicrobial Properties in Medical Devices:
EVŌQ MedTech has focused on embedding the antimicrobial capabilities of EVQ-218 within various medical devices. By collaborating with prominent catheter manufacturers, they are working towards minimizing healthcare-associated infections (HAIs), which currently affect over one million hospitalized patients each year.

3. Sustainable Solutions for Textiles:
With the help of FUZE Technologies, EVŌQ Nano is developing antimicrobial technologies for diverse industries, including textiles and hospitality. This technology, already approved by the EPA, is free of harmful chemicals and promotes sustainability, aligning with the efforts of renowned brands like Nike and Hilton.

Growing Beyond Boundaries

As EVŌQ Nano continues to innovate, their technology holds promise across various sectors beyond healthcare. In the energy industry, they seek to protect critical infrastructure from corrosion while enhancing battery longevity. Similarly, in agriculture, this technology aims to combat plant pathogens, ensuring food safety throughout the supply chain.

About the Visionary Tony Robbins

Tony Robbins has a long-standing reputation as a peak performance coach and bestselling author. With over four decades in the industry, he has guided countless leaders and organizations towards transformative success. His philanthropic endeavors have positively impacted millions globally, demonstrating his dedication to improving lives through education and empowerment.

About EVŌQ Nano

EVŌQ Nano stands out for engineering unique nanoparticles tailored for the life sciences, material science, and textile industries. Utilizing a patented process to manufacture high-volume, sub-10 nm nanoparticles, the company is at the forefront of nanotechnology, turning scientific advancements into practical solutions.

For more information regarding EVŌQ Nano's initiatives and technologies, visit evoqnano.com.

• ---